Novolog (Insulin Aspart Injection) - Reports of Side Effects and Adverse Reactions

Rx drug information, pharmaceutical research, clinical trials, news, and more

Drugs by Name

Drugs by Condition

Drugs by Category

Alerts

Novolog Rx

Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information Adverse Event Reports

Novolog News

News in Media Published Studies Curr't Clinical Trials

Nutrilib.com A comprihensive source of nutritional information

This is an index of adverse event reports related to Novolog (Insulin Aspart Injection). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (111)

     Blood Glucose Increased (51), Blood Glucose Decreased (16), Hypoglycaemia (9), more >>

Cases resulting in a serious event (56)

     Blood Glucose Increased (20), Blood Glucose Decreased (12), Hypoglycaemia (9), more >>

Cases resulting in death (1)

     Medication Error (1), Device Malfunction (1), Pharmaceutical Product Complaint (1)

Cases resulting in life threatening events (15)

     Diabetic Ketoacidosis (4), Convulsion (3), Loss of Consciousness (3), more >>

Cases resulting in hospitalization (27)

     Blood Glucose Increased (11), Blood Glucose Decreased (5), Diabetic Ketoacidosis (4), more >>

Cases resulting in disability (1)

     Hypoglycaemia (1), Convulsion (1), Atonic Seizures (1)

Cases resulting in other serious reactions (31)

     Blood Glucose Increased (9), Blood Glucose Decreased (8), Loss of Consciousness (7), more >>

Below is a sample of adverse event reports reports related to Novolog (Insulin Aspart Injection). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 49 year old male receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 49 year old male

Adverse reactions / side effects: Expired Drug Administered, Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

Adverse event in 79 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 79 year old female

Adverse reactions / side effects: Blood Glucose Decreased, Vision Blurred, Asthenia, Feeling Cold

Suspect drug(s):
Levemir
    Dosage: subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2005-01-01

Novolog
    Dosage: subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2005-01-01

Adverse event in 48 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient: 48 year old female

Adverse reactions / side effects: Injection Site Reaction

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in 62 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 62 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
    Dosage: 50 u, bid, subcutaneous
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2005-01-01

Novolog
    Dosage: sliding scale, qd, subcutaneous
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2005-01-01

Adverse event in 75 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 75 year old female

Adverse reactions / side effects: Blood Glucose Fluctuation

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Adverse event in 45 year old male receiving Novolog (Insulin Aspart Injection)

Reported by a physician from United States on 2007-10-30

Patient: 45 year old male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Novolog MIX 70 / 30
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Adverse event in female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Other drugs received by patient: Lantus

Adverse event in 73 year old male receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 73 year old male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: 12 iu, qd at night, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: 5 iu, tid, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in 49 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 49 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: 18 u, qd, subcutaneous
Indication: Type 1 Diabetes Mellitus

Novolog
Dosage: 6 u, tid, subcutaneous
Indication: Type 1 Diabetes Mellitus

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

Adverse event in 71 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 71 year old female

Adverse reactions / side effects: Injection Site Bruising

Suspect drug(s):
Levemir
    Dosage: subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2005-01-01
    End date: 2006-01-01

Novolog
    Dosage: subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2005-01-01
    End date: 2006-01-01

Adverse event in 32 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 32 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

Adverse event in 64 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 64 year old female

Adverse reactions / side effects: Blood Glucose Fluctuation

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus

Adverse event in 65 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 65 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Blood Glucose Decreased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

Adverse event in 61 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 61 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: 88 iu, qd, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: 50 iu, qd + sliding scale, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in 71 year old male receiving Novolog (Insulin Aspart Injection)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 71 year old male

Adverse reactions / side effects: Aphthous Stomatitis

Suspect drug(s):
Levemir
Dosage: 50 u, qd, subcutaneous
Start date: 2006-12-01

Novolog
    Dosage: subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2006-12-01

Adverse event in 72 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 72 year old female

Adverse reactions / side effects: Injection Site Bruising

Suspect drug(s):
Levemir
Dosage: 60 iu, qd (evening), subcutaneous; 20 iu, qd (evening), subcaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: 13 iu, bid, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Other drugs received by patient: Plavix

Adverse event in 62 year old male receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 62 year old male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Reported by a pharmacist from United States on 2007-10-30

Patient: male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subuctaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

Adverse event in 66 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 66 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in 78 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 78 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir
    Dosage: subcutaneous
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2007-07-29

Novolog
    Dosage: subcutaneous
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2007-07-29

Adverse event in 58 year old female receiving Novolog (Insulin Aspart Injection)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 58 year old female

Adverse reactions / side effects: Injection Site Haemorrhage

Suspect drug(s):
Levemir
Dosage: 75 u, qd, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Novolog
Dosage: 40 iu, qd, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Reported by a physician from United States on 2007-10-30

Patient: male

Adverse reactions / side effects: Wrong Drug Administered, NO Adverse Drug Reaction

Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus

Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus

-- advertisement --

We comply with
HONcode standard.
Verify here.

Home | About Us | Contact Us | Site usage policy | Privacy policy

Novolog (Insulin Aspart Injection) - Reports of Side Effects & Adverse Reactions

Novolog Rx

Novolog News

Adverse event in 49 year old male receiving Novolog (Insulin Aspart Injection)

Adverse event in 79 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 48 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 62 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 75 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 45 year old male receiving Novolog (Insulin Aspart Injection)

Adverse event in female receiving Novolog (Insulin Aspart Injection)

Adverse event in 73 year old male receiving Novolog (Insulin Aspart Injection)

Adverse event in 49 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Adverse event in 71 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 32 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Adverse event in 64 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 65 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in female receiving Novolog (Insulin Aspart Injection)

Adverse event in 61 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 71 year old male receiving Novolog (Insulin Aspart Injection)

Adverse event in 72 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 62 year old male receiving Novolog (Insulin Aspart Injection)

Adverse event in male receiving Novolog (Insulin Aspart Injection)

Adverse event in 66 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 78 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in 58 year old female receiving Novolog (Insulin Aspart Injection)

Adverse event in male receiving Novolog (Insulin Aspart Injection)